Capital Research Global Investors’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Capital Research Global Investors's ORCL Position: Q2 2026 in Review
Capital Research Global Investors increased its Oracle (ORCL) stake by 24% in Q2 2026, buying an estimated $1.38B and bringing the position to 39,746,237 shares worth $5.82B. The position accounts for 0.81% of the portfolio, ranked #28.
Capital Research Global Investors first reported a position in ORCL in Q2 2013 and has held it in 29 quarters since. The position peaked at $7.08B in Q2 2017. 3,521 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Capital Research Global Investors held 39,746,237 shares of Oracle worth $5.82B as of Q2 2026.
- Capital Research Global Investors bought 7,606,983 Oracle shares in Q2 2026, an estimated $1.38B.
- Oracle made up 0.81% of Capital Research Global Investors's portfolio in Q2 2026, its #28 holding.
- Capital Research Global Investors first reported a position in Oracle in Q2 2013 and has held it in 29 quarters since.
- Capital Research Global Investors's Oracle position peaked at $7.08B in Q2 2017.
- 3,521 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.